Small molecule companies
As of Oct 2026, Radar classifies 541 companies as Small molecule; 42 of them have job postings observed in our sources.
Companies
Amgen FDA-approved therapeutic company FDA-cleared device company Clinical Phase 3
Merck & Co., Inc. FDA-approved therapeutic company FDA-cleared device company Clinical Phase 3
Bristol-Myers Squibb FDA-approved therapeutic company FDA-cleared device company Clinical Phase 3
Gilead FDA-approved therapeutic company Clinical Phase 3
Viatris (2) FDA-approved therapeutic company Clinical Phase 3
Ipsen FDA-approved therapeutic company Clinical Phase 3
Biogen FDA-approved therapeutic company FDA-cleared device company Clinical Phase 3
Cytokinetics FDA-approved therapeutic company Clinical Phase 3
Exelixis FDA-approved therapeutic company Clinical Phase 3
Nurix Therapeutics Clinical Phase 3
Travere Therapeutics FDA-approved therapeutic company Clinical Phase 3
IDEAYA Biosciences Clinical Phase 3
PTC Therapeutics FDA-approved therapeutic company Clinical Phase 3
Immunome Clinical Phase 3
Mineralys Therapeutics Clinical Phase 3
Kymera Therapeutics, Inc. Clinical Phase 2
Ocular Therapeutix FDA-approved therapeutic company FDA-cleared device company Clinical Phase 3
Olema Oncology Clinical Phase 3
Tango Therapeutics, Inc. Clinical Phase 2
BioCryst Pharmaceuticals FDA-approved therapeutic company Clinical Phase 3
Cogent Biosciences, Inc. FDA-cleared device company Clinical Phase 3
Kura Oncology FDA-approved therapeutic company Clinical Phase 3
Akebia Therapeutics Clinical Phase 3
Genesis Therapeutics
SpringWorks Therapeutics FDA-approved therapeutic company Clinical Phase 3
Alumis Clinical Phase 3
Antares Therapeutics Clinical Phase 2
cAMPfield Therapeutics
Lycia Therapeutics Clinical Phase 1
Remix Therapeutics Clinical Phase 2
Skyhawk Therapeutics Clinical Phase 3
Lexeo Therapeutics Clinical Phase 2
Topos Bio
Atavistik Bio Clinical Phase 2
Magnet Biomedicine
Nuvalent FDA-approved therapeutic company Clinical Phase 3
Valo Health
Alterome Therapeutics Clinical Phase 1
Arvinas, Inc FDA-approved therapeutic company Clinical Phase 2
Flare Therapeutics Clinical Phase 1
Nimbus Therapeutics
Terremoto Biosciences Clinical Phase 2
149 Bio LLC
3B Pharmaceuticals GmbH
4E Therapeutics
7 Hills Pharma Clinical Phase 2
858 Therapeutics Clinical Phase 2
A2A Pharmaceuticals Inc.
Aardvark Therapeutics Clinical Phase 3
Abalone Bio, Inc.
ABLi Therapeutics, Inc.
AcceleDev
Accent Therapeutics Clinical Phase 2
Accuitis
Acelot
Acrotech Biopharma FDA-approved therapeutic company Clinical Phase 3
Actio Biosciences FDA-cleared device company Clinical Phase 2
Acurx Pharmaceuticals Clinical Phase 2